Arvaya HealthcareBOM:524723 +5.00%49 Median PS Value is ₹28.31 as of Jul. 08, 2026, which is 100% below its 10-year median of 1.72. GuruFocus rates BOM:524723 with a GF Score™ of 49/100 and a GF Value™ of ₹49.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 70 Medical Distribution companies, Arvaya Healthcare ranks worse than 94.29% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Arvaya Healthcare's Median PS Value or its related term are showing as below:
BOM:524723'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.48 Med: 1.72 Max: 2.61
Current: 2.61
During the past 13 years, the highest Price to Median PS Value of Arvaya Healthcare was 2.61. The lowest was 1.48. And the median was 1.72.
BOM:524723's Price-to-Median-PS-Value is ranked worse than 94.29% of 70
companies
in the Medical Distribution industry
Industry Median: 0.825
vs BOM:524723: 2.61
Arvaya Healthcare (BOM:524723) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Arvaya Healthcare's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
73.98
/
28.31
=
2.61
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvaya Healthcare Median PS Value Related Terms
Arvaya Healthcare Median PS Value Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524723 vs MCK, CAH, COR: Median PS Value Comparison
For the Medical Distribution subindustry, Arvaya Healthcare's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 15.1309.
Arvaya Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.871.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvaya Healthcare (BOM:524723) has a Median PS Value of ₹28.31 as of Jul. 08, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Arvaya Healthcare and its competitors. This is 1546% above median its historical median of 1.72. Over the past decade, Arvaya Healthcare's Median PS Value has ranged from 1.48 to 2.61. According to the industry distribution chart, Arvaya Healthcare ranks #66 out of 70 companies in the Medical Distribution industry, placing it in the top 94.3%.
Is Arvaya Healthcare's Median PS Value too high?
Arvaya Healthcare's current Median PS Value of ₹28.31 is 1546% above median its 10-year median of 1.72. Over the past 10 years, this metric has ranged from a low of 1.48 to a high of 2.61. Based on the distribution chart, Arvaya Healthcare ranks #66 out of 70 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Arvaya Healthcare has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's Median PS Value compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #66 out of 70 companies for Median PS Value. This places Arvaya Healthcare in the lower half of its industry. The industry median Median PS Value is 0.83. Historically, Arvaya Healthcare's own Median PS Value has ranged from 1.48 to 2.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.83, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current Median PS Value is ₹28.31, which is 1546% above median its own 10-year median of 1.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹49.15, compared to a current price of ₹73.98 — trading 50.5% above its estimated fair value. The current Median PS Value is ₹28.31, which is 1546% above median its 10-year median of 1.72. Arvaya Healthcare's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current Median PS Value is ₹28.31 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹73.98 is trading 50.5% above its estimated GF Value™ of ₹49.15.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
Median PS Value: ₹28.31 (1546% above median its 10-year median of 1.72)
GF Value™: ₹49.15 vs. price of ₹73.98 (50.5% above fair value)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
49GF Score
Get the complete analysis for BOM:524723
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
